Prestige appoints new VP operations
IRVINGTON, N.Y. — Prestige Brands on Friday named Paul Hennessey VP operations.
“Paul’s background in over-the-counter consumer products is a terrific match for our company,” stated Prestige president and CEO Matthew Mannelly. “As we continue to grow and become even more customer- and consumer-focused in OTC, Paul’s leadership skills and extensive experience in supply chain manufacturing will serve our brands and our company well."
Hennessey joins Prestige from Pfizer Consumer Healthcare, where he spent 18 years in supply chain and manufacturing operations in positions of increasing responsibility.
NSAIDs could pose erectile dysfunction risk among men
PASADENA, Calif. — Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.
The study, sponsored by Kaiser Permanente and published online in the Journal of Urology, found that men who took nonsteroidal anti-inflammatory drugs, or NSAIDs, three times a day for more than three months were 2.4 times as likely to have erectile dysfunction as men who didn’t take the drugs regularly. The study used data from 80,966 men ages 45 to 69 years in California.
After controlling for such factors as age, race, ethnicity, smoking, diabetes and cardiovascular disease, the researchers found the risk was 1.4 times as high in regular users of NSAIDs.
“We went into this study thinking we would find the opposite effect: that NSAIDs would have a protective effect because they protect against heart disease, which is also linked to [erectile dysfunction],” study senior author Steven Jacobsen said. “The next step is to dive a bit deeper to understand the underlying physiology of what might be happening with these drugs.”
ECRM presents awards to three suppliers
ORLANDO, Fla. — ECRM on Wednesday evening announced the Vendor Award recipients for its ECRM Cough & Cold and Allergy event held here, recognizing GOJO Industries for the “Most Prepared,” the Emerson Group for “Best Room” and Cobalis for “Best New Product.”
The awards, sponsored by The Drug Store News Group, represent a tally of retail buyer votes on each of the categories.
GOJO Industries is preparing to relaunch its Purell hand sanitizer business after acquiring that brand back from Johnson & Johnson last year. Under the direction of sales VP Tim Cleary, GOJO’s team of seven sales representatives showcased for buyers the Purell brand heritage and how the company plans to better position the brand in the coming months and years.
The Emerson Group showcased its host of client companies, including Similasan, Fleming Pharmaceuticals and Dynova Labs, among others, in a grand ballroom sporting a "winter wonderland" theme.
Cobalis was recognized for its introduction of PreHistin, a supplement ideal for allergy sufferers as it helps regulate the function of histamines. The new product is available as a quick-dissolve cherry lozenge.